Treatment response to esketamine nasal spray in patients with major depressive disorder and acute suicidal ideation or behavior without evidence of early response: a pooled post hoc analysis of ASPIRE.

Turkoz, Ibrahim; Lopena, Oliver; Salvadore, Giacomo; Sanacora, Gerard; Shelton, Richard; Fu, Dong-Jing

Turkoz, Ibrahim; Lopena, Oliver; Salvadore, Giacomo; Sanacora, Gerard; Shelton, Richard; Fu, Dong-Jing.

Afiliación

Turkoz I; Department of Statistics & Decision Sciences, Janssen Research & Development, LLC, Titusville, NJ, USA.
Lopena O; Department of Neuroscience, Janssen Scientific Affairs, LLC, Titusville, NJ, USA.
Salvadore G; Department of Neuroscience Experimental Medicine, Janssen Research & Development, LLC, Titusville, NJ, USA.
Sanacora G; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Shelton R; Department of Psychiatry, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Fu DJ; Deparment of Neuroscience, Janssen Research & Development, LLC, Titusville, USA.

CNS Spectr ; : 1-7, 2022 Jul 29.

Article en En | MEDLINE | ID: mdl-35904046

Palabras clave

Esketamine nasal spray; esketamine; major depressive disorder; responder; suicidality

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: CNS Spectr Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google